SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Further concentrate purchase

1 Oct 2007 07:02

Celtic Resources Holdings PLC01 October 2007 1 October 2007 Celtic Resources Holdings Plc ("Celtic" or the "Company") Celtic enters into agreement to purchase concentrates Celtic is pleased to announce that it has entered into an agreement with asubsidiary of European Goldfields Limited, Hellas Gold S.A. ("Hellas Gold"), forthe purchase of 50,000 tonnes of concentrates containing approximately 30,000 ozof gold. As announced on 22 September 2006, the Company acquired 9,000 tonnes ofconcentrate containing approximately 6,000 oz of gold, to be processed on atrial basis, by Celtic at its Suzdal BIOX(R) plant in Kazakhstan. The Companyalso announced that, if the initial shipments proved successful, it intended topurchase up to an additional 120,000 tonnes of concentrates from Hellas Gold.The Company has been very satisfied by the results of the trial and is thereforeannouncing an agreement to purchase a further 50,000 tonnes of concentrates,with shipments expected to be completed by the end of September 2009. The Company operates the only BIOX(R) plant in the FSU for the treatment ofrefractory sulphide ores and in addition to treating ore produced at its Suzdalmine, it will be utilising available BIOX(R) capacity to produce more gold. Suzdal has produced over 28,599 oz of gold in the last three months, whichincludes 11,780 oz produced in September, at an average sale price of US$718 peroz. Kevin Foo, Managing Director of Celtic, said, "We have been delighted with theresults of our initial trial to process third party concentrates at our SuzdalBIOX(R) plant. This agreement is a significant step forward in our strategy tocapitalise on our technology advantages at Suzdal and we are also looking atother third party concentrate opportunities within Kazakhstan and Russia, asmany refractory gold ores remain unexploited." Contact information: Kevin Foo / Jonathan Scott-BarrettCeltic Resources Holdings PlcTel: + 44 (0)20 7921 8800Investors@celtic resources.com Leesa Peters / Jane StaceyConduit PRTel: +44 (0)20 7429 6606 / (0)792 292 3306leesa@conduitpr.com Anthony CardewCardew GroupTel: +44 (0)20 7930 0777anthony.cardew@cardewgroup.com Strand Partners LimitedSimon RaggettStuart FaulknerTel: +44 (0)20 7409 3494 About the Suzdal BIOX(R) plant: Celtic has successfully developed the first BIOX(R) plant for treatment ofrefractory sulphide ores in the FSU at its Suzdal mine in Kazakhstan. The plantuses a sulphide oxidation process for recovering gold from refractory ores orconcentrates. The process utilises a mixed population of naturally occurringbacteria, that are present in all sulphide ores, to break down the sulphidemineral matrix, thereby liberating the occluded gold for subsequent cyanidation. The BIOX(R) process acts as an alternative to conventional processes of roastingand pressure oxidation and offers advantages of reduced capital cost, simplicityof operations, robustness and very low environmental impact. Any person who is the holder of 1 per cent. or more of any class of shares inCeltic may be required to make disclosures pursuant to Rule 8.3 of the IrishTakeover Panel Act, 1997, Takeover Rules 2001 to 2006. The Directors of Celtic accept responsibility for the information contained inthis announcement and to the best of their knowledge and belief (having takenall reasonable care to ensure that such is the case), the information containedin this announcement is in accordance with the facts and, where appropriate,does not omit anything likely to affect the import of such information. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Dec 20245:07 pmRNSPosting of Annual Report and Notice of AGM
13th Dec 202412:10 pmRNSPDMR Shareholding
6th Dec 20242:25 pmRNSExercise of Options and Total Voting Rights
2nd Dec 20247:00 amRNSTotal Voting Rights
22nd Nov 20245:45 pmRNSExercise of options, PDMR dealings and TVR
19th Nov 20242:07 pmRNSReplacement - Purchase, Options Exercise, Dividend
19th Nov 20247:01 amRNSPDMR Shareholdings
19th Nov 20247:00 amRNSShare Purchase, Options Exercise, Div Declaration
18th Nov 20247:00 amRNSFinal Results
14th Nov 20247:00 amRNSDate of Final Results and Online Presentation
21st Oct 20247:00 amRNSTrading Update
2nd Sep 20247:00 amRNSTotal Voting Rights
14th Aug 20244:31 pmRNSTR-1 Notification
1st Aug 20247:00 amRNSRe: Share Options,Treasury Shares,Block Admission
24th Jul 20244:12 pmRNSShare Purchase
1st Jul 20247:00 amRNSRe: Nomad and Joint Broker
13th May 20247:00 amRNSInvestor Presentation
13th May 20247:00 amRNSMajor New Contract
13th May 20247:00 amRNSInterim Results
7th May 20245:42 pmRNSTR-1 Notification
7th May 20247:00 amRNSTR-1 Notification
22nd Apr 20247:00 amRNSTrading Update
13th Mar 20247:00 amRNSShare Purchase
13th Feb 20245:27 pmRNSTR-1 Notification
13th Feb 20245:22 pmRNSTR-1
1st Feb 20243:30 pmRNSResult of AGM
15th Dec 20234:15 pmRNSPosting of Annual Report and Notice of AGM
21st Nov 20235:34 pmRNSPDMR Shareholding
20th Nov 20237:00 amRNSFinal Results
17th Nov 20237:00 amRNSNotice of Results and Online Presentation
7th Nov 20237:00 amRNSLatest product release incorporates Generative AI
2nd Nov 20237:00 amRNSMajor new customer win with Tier-1 Telco
16th Oct 20237:00 amRNSTrading Update
25th Sep 202311:53 amRNSHolding(s) in Company
6th Jul 20237:00 amRNSCompletion of Initial Implementation at Telesur
21st Jun 20237:00 amRNSMajor new contract
22nd May 20237:00 amRNSGartner Market Guide Reports
15th May 20237:00 amRNSHalf-year Report
4th May 20237:00 amRNSDate of Interim Results and Investor Presentation
17th Apr 20237:00 amRNSH1 2023 Trading Update
31st Mar 20237:00 amRNSMajor New Contract
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:32 pmRNSHolding(s) in Company
21st Feb 20237:00 amRNSCompletion of Major Implementation
2nd Feb 20232:19 pmRNSResult of AGM
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20227:00 amRNSGrant of Options and PDMR Shareholding
15th Dec 20225:20 pmRNSHolding(s) in Company
2nd Dec 20222:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.